A phase II study of lapatinib and dose-dense temozolomide (TMZ) for adults with recurrent ependymoma: A cern clinical trial Meeting Abstract


Authors: Gilbert, M.; Yuan, Y.; Wani, K.; Wu, J. M.; Omuro, A.; Lieberman, F.; Robins, H. I.; Gerstner, E.; Wu, J.; Wen, P.; Mikkelsen, T.; Armstrong, T.; Aldape, K.
Abstract Title: A phase II study of lapatinib and dose-dense temozolomide (TMZ) for adults with recurrent ependymoma: A cern clinical trial
Meeting Title: 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
Journal Title: Neuro-Oncology
Volume: 16
Issue: Suppl. 5
Meeting Dates: 2014 Nov 13-16
Meeting Location: Miami, FL
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2014-11-01
Start Page: v13
Language: English
ACCESSION: WOS:000350452200053
DOI: 10.1093/neuonc/nou237.23
PROVIDER: wos
PMCID: PMC4217801
Notes: Meeting Abstract: AT-23 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Antonio Marcilio Padula Omuro
    204 Omuro